Australia's most trusted
source of pharma news
Friday, 03 May 2024
Posted 19 April 2024 AM
Early-stage ventures are quickly taking up residence at CSL's much-awaited Melbourne-based facility inside its global headquarters after being selected for the Jumar Bioincuabtor.
While CSL welcomed its first resident in October 2023, the official opening was held this week and hosted alongside its founding partners WEHI, and the University of Melbourne, as well as initial investor Breakthrough Victoria and operator Cicada Innovations.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.